These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Clonazepam in the treatment of panic disorder with or without agoraphobia: a dose-response study of efficacy, safety, and discontinuance. Clonazepam Panic Disorder Dose-Response Study Group. Rosenbaum JF; Moroz G; Bowden CL J Clin Psychopharmacol; 1997 Oct; 17(5):390-400. PubMed ID: 9315990 [TBL] [Abstract][Full Text] [Related]
6. Valproate and carbamazepine in the treatment of panic and posttraumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes. Keck PE; McElroy SL; Friedman LM J Clin Psychopharmacol; 1992 Feb; 12(1 Suppl):36S-41S. PubMed ID: 1541716 [TBL] [Abstract][Full Text] [Related]
7. Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages. Moroz G; Rosenbaum JF J Clin Psychiatry; 1999 Sep; 60(9):604-12. PubMed ID: 10520979 [TBL] [Abstract][Full Text] [Related]
8. Benzodiazepine treatment of panic and agoraphobic symptoms: use, dependence, toxicity, abuse. Salzman C J Psychiatr Res; 1993; 27 Suppl 1():97-110. PubMed ID: 7908335 [TBL] [Abstract][Full Text] [Related]
9. Clinical features of cocaine-induced panic. Louie AK; Lannon RA; Rutzick EA; Browne D; Lewis TB; Jones R Biol Psychiatry; 1996 Nov; 40(9):938-40. PubMed ID: 8896786 [No Abstract] [Full Text] [Related]
10. Withdrawal and detoxification from benzodiazepine dependence: a potential role for clonazepam. Albeck JH J Clin Psychiatry; 1987 Oct; 48 Suppl():43-9. PubMed ID: 2889723 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic response to benzodiazepine in panic disorder subtypes. Valença AM; Nardi AE; Mezzasalma MA; Nascimento I; Zin WA; Lopes FL; Versiani M Sao Paulo Med J; 2003 Mar; 121(2):77-80. PubMed ID: 12870055 [TBL] [Abstract][Full Text] [Related]